FundedIQ
Health Care

Elasmogen

Elasmogen is developing soloMERs: fully humanized, next generation, single chain therapeutics for auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical candidates derived from VNARS (variable new-antigen receptors) which exist naturally in sharks as high affinity binding domains. With a different ancestral origin from antibodies this example of 400 million year old convergent evolution places VNARs outside of the complex patent landscape that describes and protects antibody drug discovery and has produced the smallest (9% of the size of an antibody) and most robust naturally occurring binding domain. Elasmogen is unique in its capacity to isolate and develop soloMERs, with a multi-layered IP position covering the platform, products and process including an exclusive license to over 20 patents granted in the US, Europe and other territories together with the entire know-how and VNAR pipeline/product output from the Scottish Biologics Facility, University of Aberdeen.

www.elasmogen.com Aberdeen, United Kingdom 11-50 employees
Total raised
$9.9M
Rounds
1
Latest
Venture - Series Unknown
May 2022

Elasmogen is developing soloMERs: fully humanized, next generation, single chain therapeutics for auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical candidates derived from VNARS (variable new-antigen receptors) which exist naturally in sharks as high affinity binding domains. With a different ancestral origin from antibodies this example of 400 million year old convergent evolution places VNARs outside of the complex patent landscape that describes and protects antibody drug discovery and has produced the smallest (9% of the size of an antibody) and most robust naturally occurring binding domain. Elasmogen is unique in its capacity to isolate and develop soloMERs, with a multi-layered IP position covering the platform, products and process including an exclusive license to over 20 patents granted in the US, Europe and other territories together with the entire know-how and VNAR pipeline/product output from the Scottish Biologics Facility, University of Aberdeen.

Elasmogen has raised $9.9M across 1 round. Its most recent round was a Venture - Series Unknown of $9.9M in May 2022. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
May 18, 2022
Venture - Series Unknown
$9.9M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Elasmogen is featured in

Similar companies

Gladys

Gladys is an innovative social care software platform that aims to revolutionize the caregiving industry by cutting out middlemen and connecting local carers, helpers, and families in a digital ecosystem. With a team of experienced founders, Gladys is well-equipped to address the challenges of the social care sector. As a female-led tech company in the UK, Gladys is focused on driving change, streamlining processes, and improving the quality of care for vulnerable individuals. Supported by venture capital firm Antler, Gladys is positioned to transform social care by empowering caregivers and families.

Seed $2.0M
Good Life Sorted

Great Life Sorted is a web-based stage they interfacing old individuals with reviewed, nearby Helpers. They constructing a multitude of Helpers who are nearby, trusted and verified, making home assistance reasonable by isolating home assistance from individual consideration. they benefits work across hampshire, wiltshire, dorset, sussex and kent, empowering the old to remain free in their own homes to the extent that this would be possible.

Equity Crowdfunding $30k
Leo Cancer Care

Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills hope. Founded in Australia, Leo Cancer Care is grounded in international research on the advantages of upright patient positioning. Through a shift from machine rotation to patient rotation, Leo Cancer Care is positioned to revolutionize radiation therapy.

Venture - Series Unknown $40.0M
Seluna

Seluna strongly feels that innovation and accurate diagnosis are essential components of contemporary healthcare. She is dedicated to addressing intricate medical issues in order to have a meaningful impact.

Seed $880k
IgniteData

IgniteData is transforming the landscape of clinical trials with its cloud-based virtual research assistant, Archer. Archer, an international EHR-to-EDC platform tailored for contemporary clinical trials, ensures safe transmission of clinical data. The primary goal of IgniteData is to support researchers in efficiently gathering trial data, thereby accelerating the availability of vital treatments to patients.

Series A $8.1M
Superior Wellness

Superior Spas is a company that focuses on producing hot tubs, swim spas, and related products. They serve both trade and retail customers, providing a wide selection of brands including Platinum Spas, Thermal Spas by Superior Wellness, Be Well, California Spas, and an online range. Additionally, they offer OEM services and have a network of partners worldwide to distribute their high-end hot tubs and swim spas. Superior Spas also offers direct container delivery for distributing their products in the UK.

Series Unknown $3.1M
Digostics

Digostics has created a glucose tolerance testing system for home use that helps users save money while also minimizing the risks of diabetes and cardiovascular diseases. Their innovative approach to home testing sets them apart from others in the industry.

Series Unknown $700k
Little Journey

Little Journey is an eSupport platform designed to psychological prepare and support children and their families undergoing healthcare procedures, whether as part of routine care or a clinical trial, to improve mental and physical wellbeing, and enhance patient experiences of care.

Series A $400k
Punto Health

AI-powered digital platform for management of Alzheimer's and other dementias.

Series Unknown $110k
Voda

Voda is developing a mental health platform specifically tailored for LGBTQIA+ individuals that is both empowering and efficient.

Pre-Seed $870k
Ceryx Medical

Ceryx Medical is creating bioelectronics using special chip technology that imitates nerve centers in the body known as Central Pattern Generators (CPGs). These CPGs assist in regulating various automatic processes in the body like digestion, heart rate, and walking. The goal is for Ceryx's artificial CPGs to restore proper function in cases where these processes have been disrupted by illness or injury.

Series Unknown $6.7M
Perci Health

Perci Health offers telehealth services for individuals with cancer, with the goal of altering views on post-treatment life.

Seed $4.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.